Related Experiment Video
Updated: Sep 18, 2025

09:41
Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
13.5K
Dysregulated monocyte compartment in PACS patients
Romy Kronstein-Wiedemann1,2, Madeleine Teichert2, Elisa Michel3
1Laboratory for Experimental Transfusion Medicine, Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Frontiers in Immunology
|June 23, 2025
Summary
Post-acute sequelae of COVID-19 (PACS) patients show altered monocyte subsets, specifically increased intermediate and CD56+ monocytes. Cognitive dysfunction in PACS is linked to higher non-classical monocyte counts, suggesting immune dysregulation.
Area of Science:
- Immunology
- Virology
- Hematology
Background:
- Post-acute sequelae of COVID-19 (PACS) affect 1-5% of patients, causing persistent symptoms like fatigue and cognitive dysfunction.
- Immune dysregulation, involving monocytes and cytokines, is implicated in PACS pathogenesis.
- Understanding monocyte subpopulation changes is crucial for elucidating PACS mechanisms.
Purpose of the Study:
- To investigate the impact of PACS on peripheral blood monocyte subpopulations.
- To identify specific monocyte subset alterations associated with PACS symptoms.
Main Methods:
- Flow cytometry was used to analyze monocyte subpopulations in peripheral blood.
- Hematological parameters and blood gas analysis were performed.
- PACS patients were compared with healthy donors.
Main Results:
- PACS patients exhibited increased intermediate and CD56+ monocyte counts compared to healthy controls.
- Total, classical, and non-classical monocyte counts were not significantly different overall.
- Cognitive dysfunction in PACS patients correlated with elevated non-classical monocyte numbers.
Conclusions:
- A disturbed homeostasis of monocyte subsets is present in PACS patients.
- Specific monocyte alterations may be linked to particular PACS symptoms, such as cognitive dysfunction.

